Erypeg 30 mcg PFS is a class of medications called erythropoiesis-stimulating agents (ESAs). Erypeg 30 mcg Injection is used in the treatment of anaemia that may have occurred due to chronic kidney disease or chemotherapy. Erypeg 30 stimulates the bone marrow to produce more red blood cells.
Erypeg 30 mcg may cause frequent flu-like symptoms including headaches, joint pain, fever, weakness, fatigue, and dizziness. These symptoms may be more prominent during the early stages of treatment. If you experience them during intravenous injection, a slower injection delivery rate may help reduce them. Erypeg 30 mcg PFS may also result in common side effects such as chest pain, shortness of breath, and leg swelling, which may be indicative of blood clots, diarrhoea, seizures, elevated blood pressure, and headaches. If these symptoms persist or cause discomfort, it's recommended to seek medical advice. Your doctor can guide managing any side effects
Erypeg 30 mcg PFS is not recommended for use in patients with uncontrolled high blood pressure.
Before taking Erypeg 30 mcg Injection talk to your doctor about the potential risks and benefits of taking this medication, as well as any other questions or concerns you may have and also important to let your doctor know you have any pre-existing diseases or using any medications, vitamins supplements, herbal medicine you are taking.
Erypeg 30 mcg PFS is administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of Erypeg 30 will depend on the clinical condition of the patient's age and medical history and other factors. Kindly do not self-administer.
Treatment of symptomatic anaemia associated with chronic renal failure (CRF): Erypeg 30 mcg PFS is used in the treatment of symptomatic anaemia associated with chronic renal failure (CRF) in adults and paediatric patients, including patients on dialysis and patients not on dialysis.
Treatment of anaemia due to cancer chemotherapy: Erypeg 30 mcg PFS is used in the treatment of anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.
In Treatment of Anemia due to chronic kidney disease: Erypeg 30 mcg PFS is a man-made protein that helps your bone marrow to produce more red blood cells. It is used to treat anaemia which is caused by kidney disease in adults and children who are on dialysis. Anaemia is a condition where your body does not have enough red blood cells to carry oxygen around your body. This medicine helps reduce weakness and tiredness that you may be experiencing due to anaemia. The injection is usually given by a doctor after a dialysis treatment.
In Treatment of Anemia due to cancer chemotherapy: Anemia is a condition where your body does not have enough red blood cells to carry oxygen around your body. Erypeg 30 mcg PFS is a man-made protein that stimulates the bone marrow (soft tissue inside the bones) to produce more red blood cells. The natural human form of this protein may be reduced when you are having chemotherapy to treat some types of cancer. An injection of the medicine can reduce the need for a blood transfusion. You may also be given iron supplements to make the treatment more effective.
Like all medications, Erypeg 30 mcg PFS can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Erypeg 30 mcg PFS is come in solution (liquid) and is slowly injected (infused) under the skin (subcutaneously). This medication is usually given to the tummy or thigh. For dosage and frequency of taking Erypeg 30 mcg PFS, injection is decided by your health care professional or doctor. You should inform your health care, professional or doctor if you are facing any serious side effects.
Erypeg 30 mcg PFS containing Erythropoietin is a hormone produced by the kidneys that plays a critical role in the production of red blood cells. Red blood cells are responsible for carrying oxygen from the lungs to the rest of the body. Erythropoietin is produced in response to low oxygen levels in the body. When oxygen levels are low, the kidneys release more EPO, which stimulates the production of red blood cells. As a result, the number of red blood cells in the body increases, and more oxygen is delivered to the body's tissues.
It is generally not recommended to drink alcohol while taking Erypeg 30 mcg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
Erypeg 30 mcg PFS may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Erypeg 30 mcg Injection.
Erypeg 30 mcg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Erypeg 30 mcg Injection and report any unusual symptoms or changes in liver function to their doctor. The dose of Erypeg 30 may need to be adjusted in patients with liver disease.
It is not recommended to breastfeed while taking Erypeg 30 mcg PFS. Erypeg 30 mcg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Erypeg 30, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
Use of Erypeg 30 mcg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Erypeg 30 mcg Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
Erypeg 30 mcg PFS is safe to use in patients with kidney disease. No dose adjustment of Erypeg 30 mcg Injection is recommended. If you experience any side effects please consult your doctor.
1. Epoetin Alfa Hexal 4,000 Iu/0.4 Ml Solution For Injection In A Pre-filled Syringe, Hexal Ag, Patient’s Leaflet
2. Eprex Epoetin Alfa Sterile Solution,janssen Inc. Product Monograph
3. Eprex, epoetin Alfa, Janssen-cilag (New Zealand) Ltd, [date Of Revision Of The Text 3 December 2021], Product Leaflet
4. Neorecormon 4000 Iu Solution For Injection In Pre-filled Syringe, Roche Pharma Ag, Product Leaflet